Isolated Strains of Nontuberculous Mycobacterium Interfere with Immune Responses Associated with Mycobacterium Bovis BCG Vaccination

Article Preview

Abstract:

Prior exposure of a vaccine to certain species of environmental mycobacteria can prime the immune system against common mycobacterial antigens, which can in turn reduce the subsequent efficacy of live attenuated mycobacterial vaccines (such as Mycobacterium bovis BCG), in both human and livestock vaccination programs. In this study, five strains of nontubeculous mycobacterium, all isolated from lymphonodi mandibulares and lymphonodi mesenterici samples of swine and cattle, were investigated to determine their growth characteristics and effects on the immune system in murine models. Markedly, different effects on the immune system were observed. The different results may be linked to the inherent growth characteristics of the five strains, The implications of these findings for BCG vaccination protocols are discussed.

You might also be interested in these eBooks

Info:

Periodical:

Advanced Materials Research (Volumes 884-885)

Pages:

450-454

Citation:

Online since:

January 2014

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2014 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] O. Cosivi, J. M. Grange, C. J. Daborn, M. C. Raviglione, T. Fujikura, D. Cousins, R. A. Robinson, H. F. Huchzermeyer, I. de Kantor and F. X. Meslin, Zoonotic tuberculosis due to Mycobacterium bovis in developing countries, Emerg Infect Dis. 4(1998).

DOI: 10.3201/eid0401.980108

Google Scholar

[2] P. E. Fine, Variation in protection by BCG. implications of and for heterologous immunity, Lancet. 346(1995), 1339–1345.

DOI: 10.1016/s0140-6736(95)92348-9

Google Scholar

[3] L. Brandt, C. J. Feino, O. A. Weinreich, B. Chilima, P. Hirsch, R. Appelberg and P. Andersen, Failure of the Mycobacterium bovis BCG vaccine. some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis, Infect Immun. 70(2002).

DOI: 10.1128/iai.70.2.672-678.2002

Google Scholar

[4] M. L. Edwards, J. M. Goodrich, D. Muller, A. Pollack, J. E. Ziegler and D. W. Smith, Infection with Mycobacterium avium-intracellulare and the protective effects of Bacille Calmette-Guerin, J. Infect. Dis. 145(1982), 733–741.

DOI: 10.1093/infdis/145.2.733

Google Scholar

[5] S. L. Young, L. Slobbe, R. Wilson, B. M. Buddle, L, G. de and G. S. Buchan, Environmental Strains of Mycobacterium avium Interfere Responses Associated with Mycobacterium bovis, Infect immune. 75(2007), 2833–2840.

DOI: 10.1128/iai.01826-06

Google Scholar

[6] I.M. Orme, A.R. Roberts and F.M. Collins, Lack of evidence for a reduction in the efficacy of subcutaneous BCG vaccination in mice infected with nontuberculous mycobacteria, Tubercle. 67(1986), 41–46.

DOI: 10.1016/0041-3879(86)90030-9

Google Scholar

[7] I.M. Orme and F.M. Collins, Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria, Infect Immun. 44(1984), 28–32.

DOI: 10.1128/iai.44.1.28-32.1984

Google Scholar

[8] M. Amadori, S. Tagliabue, S. Lauzi, G. Finazzi, G. Lombardi, P. Telo, L. Pacciarini and L. Bonizzi, Diagnosis of Mycobacterium bovis infection in calves sensitized by mycobacteria of the avium/intracellulare group, J Vet Med B Infect Dis Vet Public Health. 49(2002).

DOI: 10.1046/j.1439-0450.2002.00513.x

Google Scholar

[9] V. N. Chihota, N. Z. Nyazema, S. Mashingaidze and B. Mutandiro, TB infection: an exploratory study of BCG protective properties and the possible role of environmental mycobacteria, Cent Afr J Med. 44(1998), 15–148.

Google Scholar

[10] B. M. Buddle , B. J. Wards, F. E. Aldwell, D. M. Collins and G. W. de Lisle, Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis, Vaccine. 20(2002), 1126–1133.

DOI: 10.1016/s0264-410x(01)00436-4

Google Scholar